Clinical Trial Update: A Study of Brepocitinib in Adults With Active Non-Infectious Non-Anterior Uveitis [Phase 2]

View source ↗

Summary

A Phase 2 study of brepocitinib in adults with active non-infectious intermediate, posterior, or panuveitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-infectious Intermediate Uveitis
• Non-infectious Panuveitis
• Non-infectious Posterior Uveitis

Drugs mentioned

• Brepocitinib (brepocitinib)

Snippet

Sponsor: Priovant Therapeutics, Inc. | Conditions: Non-infectious Intermediate Uveitis, Non-infectious Posterior Uveitis | Phase 2 | Status: COMPLETED